← All trials
NCT07123467
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2025
- Primary completion
- Aug 31, 2027
- Completion date
- Aug 31, 2027
- First posted
- Aug 14, 2025
- Last posted
- Sep 18, 2025
- Enrollment
- 90
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Wayne State UniversityLead sponsor
- Wayne State UniversityOfficial
- National Institute of Mental Health (NIMH)Collaborator
- Wayne State UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.